A critical role for the TAR element in promoting efficient human immunodeficiency virus type 1 reverse transcription

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 4017-4027

  Harrich, David ^a   Ulich, Catherine ^a   Gaynor, Richard B ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; VIRUS RNA;

ARTICLE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; VIRUS EXPRESSION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 0029893132     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.6.4017-4027.1996     Document Type: Article

References (61)

1. Trp primer is required for efficient initiation of reverse transcription. J. Virol. 66:2464-2472.
2. Aiyar, A., Z. Ge, and J. Leis. 1994. A specific orientation of RNA secondary structures is required for initiation of reverse transcription. J. Virol. 68:611-618.
3. Aldovini, A., and R. A. Young. 1990. Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus. J. Virol. 64:1920-1926.
4. Arts, E. J., X. Li, Z. Gu, L. Kleiman, M. A. Parniak, and VI. A. Wainberg. 1994. Comparison of deoxyoligonucleotide and tRNA(Lys-3) as primers in an endogenous human immunodeficiency virus type-1 in vitro reverse transcription/template-switching reaction. J. Biol. Chem. 269:14672-14680.
5. Baltimore, D. 1970. RNA-dependent DNA polymerization in virions of RNA tumor viruses. Nature (London) 226:1209-1211.
6. Barat, C., O. Schatz, S. Le Grice, and J. L. Darlix. 1993. Analysis of the interactions of HIV-1 replication primer tRNA(Lys3) with nucleocapsid protein and reverse transcriptase. J. Mol. Biol. 231:185-190.
7. Baudin, F., R. Marquet, C. Isel, J.-L. Darlix, B. Ehresmann, and C. Ehresmann. 1993. Functional sites in the 5′ region of human immunodeficiency virus type 1 RNA form defined structural domains. J. Mol. Biol. 229:382-397.
8. Berkhout, B., and I. Schoneveld. 1993. Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site. Nucleic Acids Res. 21:1171-1178.
9. Calnan, B. J., B. Tidor, S. Biancalana, D. Hudson, and A. D. Frankel. 1991. Arginine-mediated RNA recognition: the argininc fork. Science 252:1167-1171.
10. Clavel, F., and J. M. Orenstein. 1990. A mutant of human immunodeficiency virus with reduced RNA packaging and abnormal particle morphology. J. Virol. 64:5230-5234.
11. Clever, J., C. Sassetti, and T. G. Parslow. 1995. RNA secondary structure and binding sites for gag gene products in the 5′ packaging signal of human immunodeficiency virus type 1. J. Virol. 69:2101-2109.
12. Cobrinik, D., A. Aiyar, Z. Ge, M. Katzman, H. Huang, and J. Leis. 1991. Overlapping retrovirus US equence elements are required for efficient integration and initiation of reverse transcription. J. Virol. 65:3864-3872.
13. Cobrinik, D., L. Soskey, and J. Leis. 1988. A retroviral RNA secondary structure required for efficient initiation of reverse transcription. J. Virol. 62:3622-3630.
14. -human immunodeficiency virus type 1 particles which are restricted for the preretrotranscription steps. J. Virol. 69:2068-2074.
15. Das, A. T., and B. Berkhout. 1995. Efficient extension of a misaligned tRNA-primer during replication of the HIV-1 retrovirus. Nucleic Acids Res. 23:1319-1326.
16. Dingwall, C., I. Ernberg, M. J. Gait, S. M. Green, S. Heaphy, J. Karn, A. D. Lowe, M. Singh, and M. A. Skinner. 1990. HIV-1 Tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J. 9:4145-4153.
17. Engelman, A., G. Englund, J. M. Orenstein, M. A. Martin, and R. Craigie. 1995. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69:2729-2736.
18. Feng, S., and E. C. Holland. 1988. HIV-1 Tat trans-activation requires the loop sequence within TAR. Nature (London) 334:165-167.
19. Garcia, J. A., D. Harrich, E. Soultanakis, F. Wu, R. Mitsuyasu, and K. B. Gaynor. 1989. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8:765-778.
20. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
21. Golf, S. P. 1990. Retroviral reverse transcriptase: synthesis, structure, and function. J. Acquired Immune Defic. Syndr. 3:817-831.
22. Graham, F. L., J. Smiley, W. C. Russell, and R. Nairn. 1977. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J. Gen. Virol. 36:59-72.
23. Hahn, B. H., G. M. Shaw, S. K. Arya, M. Popovic, R. C. Gallo, and S. F. Wong. 1984. Molecular cloning and characterization of the HTLV-1II virus associated with AIDS. Nature (London) 312:166-169.
24. Harrich, D., C. Hsu, E. Race, and R. B. Gaynor. 1994. Differential growth kinetics are exhibited by human immunodeficiency virus type 1 TAR mutants. J. Virol. 68:5899-5910.
25. Harrich, D., G. Mavankal, A. Mette-Snider, and R. B. Gaynor. 1995. Human immunodeficiency virus type 1 TAR element revertant viruses define RNA structures required for efficient viral gene expression and replication. J. 7 Virol. 69:4906-4913.
26. Harrison, G. P., and A. M. L. Lever. 1992. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol. 66:4144-4153.
27. Hirt, B. 1967. Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26:365-369.
28. Hu, W. S., and H. M. Temin. 1990. Retroviral recombination and reverse transcription. Science 250:1227-1233.
29. Hu, W. S., and H. M. Temin. 1990. Genetic consequence of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genomic recombination. Proc. Natl. Acad. Sci. USA 87:1556-1560.
30. Huang, L., A. Joshi, R. Willey, J. Orenstein, and K. T. Jeang. 1994. Human immunodeficiency viruses regulated by alternative trans-activators: genetic evidence for a novel non-transcriptional function of Tat in virion infectivity. EMBO J. 13:2886-2896.
31. Isel, C., R. Marquet, G. Keith, C. Ehresmann, and B. Ehresmann. 1993. Modified nucleotides of tRNA (3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-I reverse transcriptase. J. Biol. Chem. 268:25269-25272.
32. Jacks, T., M. D. Power, F. R. Masiarz, P. A. Luciw, P. J. Barr, and H. E. Varmus. 1988. Characterization of ribosomal frame-shifting in HIV-1 gag-pol expression. Nature (London) 331:280-283.
33. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
34. Klaver, B., and B. Berkhout. 1994. Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus. EMBO J. 13:2650-2659.
35. Kliewer, S., J. Garcia, L. Pearson, E. Soultanakis, A. Dasgupta, and R. Gaynor. 1989. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity. J. Virol. 63:4616-4625.
36. Kohlstaedt, L. A., J. Wang, J. M. Friedman, P. A. Rice, and T. A. Steitz. 1992. Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science 256:1783-1790.
37. Li, P., A. J. Stephenson, L. J. Kuiper, and C. J. Burrell. 1993. Double-stranded strong-stop DNA and the second template switch in human immunodeficiency virus (HIV) DNA synthesis. Virology 194:82-88.
38. Li, X., J. Mak, E. J. Arts, Z. Gu, L. Kleiman, M. A. Wainberg, and M. A. Parniak. 1994. Effects of alterations of the primer-binding site sequences on human immunodeficiency virus type 1 replication. J. Virol. 68:6198-6206.
39. Malim, M. H., L. S. Tiley, D. F. McCarn, J. R. Rusche, J. Hauber, and B. R. Cullen. 1990. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell 60:675-683.
40. Masuda, T., V. Flanelles, P. Krogstad, and I. S. Y. Chen. 1995. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain. J. Viral. 69:6687-6696.
41. Muesing, M. A., D. H. Smith, and D. J. Capon. 1987. Regulation of mRNA accumulation by a human immunodeficiency virus trans-activator protein. Cell 48:691-701.
42. Murphy, J. E., and S. P. Goff. 1989. Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription. J. Virol. 63:319-327.
43. O'Brian, W. A., A. Namazi, K. Hamidreza, S. Mao, J. A. Zack, and I. S. Y. Chen. 1994. Kinetics of human immunodeficiency virus type 1 reverse transcription in hlood mononuclear phagocytes are slowed by limitations of nucleotide precursors. J. Virol. 68:1258-1263.
44. Panel, A. C., W. A. Haseltine, D. Baltimore, G. Peters, F. Harada, and J. Dahlberg. 1975. Specific binding of tRNAtrp to AMV reverse transcriptase. Proc. Natl. Acad. Sci. USA 72:2535-2539.
45. Peliska, J. A., S. Balasubramanian, D. P. Giedroc, and S. J. Benovic. 1994. Recombinant HIV-1 nucleocapsid protein accelerates HIV-1 reverse transcriptase catalyzed DNA strand transfer reactions and modulates RNase H activity. Biochemistry 33:13817-13823.
46. Peliska, J. A., and S. J. Benkovic. 1992. Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase. Science 258:112-118.
47. Lys primer-binding site of the human immunodeficiency virus type 1 identify essential regions for reverse transcription. J. Virol. 65:4555-4564.
48. Robert, D., M. L. Sallafranque-Andreola, B. Bordier, L. Sarih-Cottin, L. Tarrago-Litvak, P. V. Graves, P. J. Barr, M. Fournier, and S. Litvak. 1990. Interactions with tRNALys induce important structural changes in human immunodeficiency virus reverse transcriptase. FEBS Lett. 277:239-242.
49. Rosen, C. A., J. G. Sodoroski, and W. A. Haseltine. 1985. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell 41:813-823.
50. Roy, S., U. Delling, C.-H. Chen, C. A. Rosen, and N. Sonenberg. 1990. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tatmediated/trans-activation. Genes Dev. 4:1365-1373.
51. Schwartz, O., V. Maréchal, O. Danos, and J.-M. Heard. 1995. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69:4053-4059.
52. Temin, H. M., and S. Mitzutani. 1970. RNA-directed DNA polymcrase in virions of Rous sarcoma virus. Nature (London) 226:1211-1213.
53. Varmus, H., and P. Brown. 1989. Retroviruses. p. 53-108. In D. E. Berg and M. M. Howe (ed.). Mobile DNA. American Society for Microbiology. Washington. D.C.
54. von Schwedler, U., J. Song, C. Aiken, and D. Trono. 1993. vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J. Virol. 67:4945-4955.
55. Wakefield, J. K., H. Rhim, and C. D. Morrow. 1994. Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site. J. Virol. 68:1605-1614.
56. Lys. J. Virol. 69:6021-6029.
57. Weeks, K. M., and D. M. Crothers. 1991. RNA recognition by Tat-derived peptides: interaction in the major groove? Cell 66:577-588.
58. Whitcomb, J. M., and S. H. Hughes. 1992. Retroviral reverse transcription and integration: progress and problems. Annu. Rev. Cell Biol. 8:275-306.
59. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. V. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
60. Zack, J. A., A. M. Haislip, P. Krogstad, and I. S. Y. Chen. 1992. Incomplete reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66:1717-1725.
61. Zakharova, O. D., L. Tarrago-Litvak, M. Fournier, M. L. Andreola, M. N. Repkova, A. G. Venyaminova, S. Litvak, and G. A. Nevinsky. 1995. Interaction of primer tRNA (Lys3) with p51 subunit of human immunodeficiency virus type 1 reverse transcriptase: a possible role in enzyme activation. FEBS Lett. 361:287-290.